In vitro drug susceptibility of Chlamydia sp. strain TWAR | Zendy

C C Kuo | Zendy; J. Thomas Grayston | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In vitro drug susceptibility of Chlamydia sp. strain TWAR

Author(s) -

C C Kuo,

J. Thomas Grayston

Publication year - 1988

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.32.2.257

Subject(s) - sulfisoxazole , chlamydia , microbiology and biotechnology , tetracycline , penicillin , erythromycin , ampicillin , in vitro , chlamydia trachomatis , antimicrobial , drug , sulfonamide , antibiotics , biology , chemistry , virology , pharmacology , immunology , biochemistry , stereochemistry

The in vitro susceptibilities of eight Chlamydia sp. strain TWAR isolates were tested against tetracycline, erythromycin, penicillin, ampicillin, sulfisoxazole, and a new drug, trospectomycin. The ranges of inhibitory concentrations of these antimicrobial agents, except for sulfonamide, were similar to those for Chlamydia trachomatis. Sulfisoxazole was not inhibitory at the highest nontoxic concentration tested.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research